Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.
about
Analysis of eight cases of neonatal meningitis and sepsis due to Enterobacter sakazakiiMoxalactam pharmacokinetics in childrenA comparative evaluation of moxalactam: antimicrobial activity, pharmacokinetics, adverse reactions, and clinical efficacy.Latamoxef and the newborn.Examination of gram-negative bacilli from meningitis patients who failed or relapsed on moxalactam therapy.Clinical evaluation of moxalactam.Single-dose pharmacokinetics of ceftriaxone in infants and young children.In vitro activity of moxalactam alone and in combination with penicillin against common meningeal pathogens.Moxalactam penetration into cerebrospinal fluid in patients with bacterial meningitisPharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis.Pharmacokinetics of cefuroxime in infants and children with bacterial meningitisPrediction of drug clearance in children 3 months and younger: an allometric approach.Comparison of cefotaxime, imipenem-cilastatin, ampicillin-gentamicin, and ampicillin-chloramphenicol in the treatment of experimental Escherichia coli bacteremia and meningitis.Cerebrospinal fluid penetration of moxalactam in ventriculostomy patients.Neonatal septicemia.A perspective on new beta-lactam antibiotics in pediatric patients.Ceftazidime in neonatal infectionsConcentrations of cefoperazone in cerebrospinal fluid during bacterial meningitisPharmacokinetics of cefoperazone in full-term and premature neonates.
P2860
Q24651206-A5FFA854-963E-4A28-BF28-4232F22C2255Q34250667-76CCCA4A-C4FA-4DBA-9CF8-C1E7EE369755Q34707883-1EE68E47-1A11-4963-A6F6-EC12A6F2A145Q35118215-D6ED9E59-2F83-48AB-817C-78DF44DFF050Q35641081-75D3DBFF-64D7-4682-9CA8-9416A2EAD3BFQ35670939-FB039639-97C1-4F91-A94A-9E21764CEA21Q35673633-9EBCB9C7-6A54-4981-9F02-DC14440C6516Q35674699-80C33EA8-42AF-46AD-B305-E1A1F579E8F3Q35674872-CCAEC48D-75A0-48F0-8D90-90F034E7B084Q35718258-5B4690BA-45D3-4F64-919C-581AFB525072Q35761827-0ED0E72F-27CC-4AA1-B11B-E82A0013FB4FQ37854677-0B183016-0B28-4602-A5D0-553C4EC6EAE3Q39850317-067AB6C4-66FF-40A5-AF4C-848858601E1FQ39850616-06B7ED05-A362-44C8-A303-3174F11BA160Q40150390-59BC61CA-FF06-4D4C-BCCB-3B2B27040026Q40177231-FE8BBCE0-5F9D-4E2F-BB64-96369BAFD9FEQ41768640-74E1B6A9-0480-41DB-82CC-5A8E21AD2622Q41866937-DFEF1115-FF88-478E-880E-8D5B96278E45Q41892422-EAD3C8EA-B015-44CA-A18A-EC076CAB17BC
P2860
Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年学术文章
@wuu
1981年学术文章
@zh
1981年学术文章
@zh-cn
1981年学术文章
@zh-hans
1981年学术文章
@zh-my
1981年学术文章
@zh-sg
1981年學術文章
@yue
1981年學術文章
@zh-hant
name
Clinical evaluation of a new b ...... ctam, in neonates and infants.
@en
Clinical evaluation of a new b ...... ctam, in neonates and infants.
@nl
type
label
Clinical evaluation of a new b ...... ctam, in neonates and infants.
@en
Clinical evaluation of a new b ...... ctam, in neonates and infants.
@nl
prefLabel
Clinical evaluation of a new b ...... ctam, in neonates and infants.
@en
Clinical evaluation of a new b ...... ctam, in neonates and infants.
@nl
P2093
P1476
Clinical evaluation of a new b ...... ctam, in neonates and infants.
@en
P2093
McCracken GH Jr
Threlkeld N
P304
P356
10.1016/S0022-3476(81)80559-8
P407
P577
1981-01-01T00:00:00Z